Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cemex SAB de CV (ADR) (CX), James Hardie Industries plc (ADR) (JHX), CRH PLC (ADR) (CRH): Are These Cement Companies Investment-Worthy?

Page 1 of 2

3 Commodities For A Housing RecoveryAs per a report from the Portland Cement Association, it is estimated that the U.S. cement industry will grow by 6.2% in the current year, up from 6% in 2012. Estimated annual consumption growth of cement will be around 11.1% for 2015-2017. Increase in cement consumption was fueled by growing construction activities in the U.S. However, Europe is facing a slump in construction activities this year due to a lack of investments in the real estate sector and weakening European economies. Let’s look at how three companies handle the economic changes affecting their industry.

Growing U.S. market

Specialty cement is used in the construction of oil wells, and increasing well construction is fueling the demand for these cement products in the U.S. To take advantage of this, Cemex SAB de CV (ADR) (NYSE:CX) recently announced the expansion of its cement plant in Texas. The plant’s production capacity will increase to 900,000 metric tons, from 350,000 metric ton currently. The company will spend around $87.5 million and one year on this expansion. Increasing production capacity will help the company to keep pace with the growing demand. Cemex SAB de CV (ADR) (NYSE:CX)’s net income will increase to $139 million in 2014, a drastic change from the loss of $904 million last year.

Recovery in the U.S. housing market is favorable for Cemex SAB de CV (ADR) (NYSE:CX), as it is one of the largest producers of cement in the U.S. It is estimated that cement consumption will increase from 81.2 million metric tons in 2012, to 88.2 million metric tons by the end of this year. To ensure the growth of the housing market, the U.S. government is also supporting residential home projects in the country by providing subsidies. Looking at the positive moves of the government and improving housing market, sales for the company are expected to surge from $3.03 billion in 2012 to $3.37 billion in the current fiscal year.

Plant upgrades

In the quarter ended in March 2013, revenue of James Hardie Industries plc (ADR) (NYSE:JHX) increased to $326.8 million, up by 5.7%, year-over-year. The growth of the company was driven by increasing sales volume in the U.S. and Asia Pacific. With this, its cost of sales was also increased 5.3%, from $213 million to $225 million in the same period, year-over-year. James Hardie Industries plc (ADR) (NYSE:JHX) is expecting growth in the U.S. housing market this year, and to capitalize on the opportunity, it made investments for plant upgrades and refurbishments of idled equipment. The company is also expecting sales to rise in its repair and remodel segment, which caters to repairing homes and upgrading parts of constructed buildings. It is expected that the company will earn around $1.5 billion in fiscal year 2014, up by 7%, year-over-year.

The Ministry of Education in New Zealand filed a lawsuit against two subsidiaries of James Hardie Industries plc (ADR) (NYSE:JHX) in April 2013. The claim is related to defective wall cladding in 300 school buildings built by the company. The company is facing allegations of weather tightness defects. It is expected that the claims will be settled out of court. The lawsuit filed by the ministry is for $1.5 billion, and any adverse decision from the court will impact the brand image of James Hardie Industries plc (ADR) (NYSE:JHX).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!